EMJ GOLD: Pharma news, views and analysis

The GOLD Podcast is back for Season 4, and it is returning with a bang as Helena speaks to Kavita Panke, Disease Area Strategy Leader, Neurodegeneration, Janssen. An inspiring pharma leader working in a rapidly evolving area of the industry, Kavita reveals the reasons behind her passion for neuroscience, how to build a high-performing team and her inspiring goals for 2023. If you're interested in...

For our fourth and final GOLD Nugget of Season 3, Helena looks back to our Catalyst interview with Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology, sharing some of Reshema's ideas for tackling clinical trial recruitment gaps, her personal take on Nelson Mandela's approach to dealing with failure and why she believes equal representation matters in the pharma industry...

Join Helena and Isabel in ringing in the new year with a special episode in which five of our previous guests share their predictions for what could lie ahead for the pharmaceutical industry in 2023. Together, they discuss a broad range of topics including greater implementation of digital health, social media's impact on the space, new legislation and much more. If you are interested in learning...

This GOLD Nugget episode sees Helena reflect on some of the best insights offered by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen. She shares some of Pav's thoughts on how the often under-recognised field of pharmacovigilance has changed – particularly its rapid evolution during the COVID-19 pandemic – and its importance as a strategic enabler, as well as Pav's advice on what phar...

In the second of four special bonus episodes, Helena looks back at GOLD's conversation with Paul Simms, CEO, Impatient Health. She considers some of the gold nuggets that Paul shared, including insights on the current state of pharma's reputation and the ways in which pharma can recover and bolster its reputation. If you're interested in learning more about the topic areas discussed in this episod...

In the first of four special bonus episodes, Helena looks back at the launch episode of Season 3, which featured Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy and Gastro-Intestinal Diseases, Sanofi. Helena considers some of the gold nuggets that Juby shared, including insights on the importance of cross-functional experience, team diversity and continual learn...

This week's season finale episode welcomes back some friends of the podcast – most of whom we interviewed on the show this year – to reflect on the past 12 months and give us their take on their key highlights. Hear Aliya Omer, Claire Gillis, Robert Grimm, Michele Manto, Paul Simms and Wendy White, unravel the past year in pharma, looking at everything from access challenges to organisational chan...

This week on the podcast, GOLD discusses the field of pharma sales with James Harper, Founder and Managing Director, twentyeightb. James shares his story of joining the pharma industry, the incredible importance of striving to add value to every customer engagement, whether MSLs and sales reps could ever converge and the priority of mindset over toolset. All this stems from the inaugural event fro...

In this week's episode, Helena and Isabel share an interview with GOLD's new catalyst John Wahba, Medical Head of the Global Digital Hub, GSK. In this teaser edition of the catalyst interview, John shares his motivations for joining the pharmaceutical industry, key takeaways from his time in the medical field, thoughts on digitally optimising MSL teams and much more. If you want to read the writte...

This week, the GOLD team presents a special episode to mark World AIDS Day, which is taking place on 1st December. Hear from Dr Nneka Nwokolo, Global Head of Patient Affairs, ViiV Healthcare, and Claire Gillis, CEO, VMLY&R Health, as they both discuss HIV stigma, prevention and care in the world today and how pharma can support healthcare professionals and patients. GOLD also speaks to former gues...

This week, GOLD chats to Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax. She reveals what it was like to join Novavax at the height of the pandemic, the importance of storytelling to ensure uptake and access to new vaccines and the advice she would give her younger self on how to succeed. If you're interested in learning more about the topic areas discussed in th...

This week, the GOLD team shares a conversation with Christoph Glaetzer, Chief Global Value and Access Officer, Johnson & Johnson. He discusses his lengthy career within value and access and his drive to enter the industry, his proudest achievements while working at J&J and the importance of having a good leader to learn from. And in news you might have missed, the team showcases some recent invest...

In this week's episode, GOLD speaks to Eugene Borukhovich, Co-Founder and COO, YourCoach. Health, about the evolving landscape of digital therapeutics. He discusses his journey into the pharmaceutical space, tips for companies looking to get into DTx and his predictions for this tech evolution over coming years. And news you might have missed showcases collaborative efforts against ebola and good...

This week, the GOLD team discusses key articles and themes from the latest magazine, drilling down into topics such as what pharma can learn from the tech giants, the industry's response to Roe v. Wade and the delicate balance of biotech success, to give listeners some exclusive context and insights on three fascinating stories affecting the industry today. If you're interested in learning more ab...

In this week's episode, GOLD speaks to Patrick Short, CEO, Sano Genetics, about the challenges and opportunities in genetic medicine today. He discusses his personal connection to tackling genetic diseases, the top reasons behind research participation hesitancy and the therapy areas in which he believes genomic testing and medicine could be most impactful. Plus, news from the World Health Summit....

In this week's episode, Helena and Isabel share an interview with GOLD's next Catalyst Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology. In this special extended version of the interview exclusive to the podcast, hear Reshema's story and insights in full, including the life experiences that have led her to where she is today, her ideas for tackling clinical trial recr...

In this week's episode, Helena is joined by Paul Simms, CEO of Impatient Health, to delve deeper into GOLD's recent cover feature on reframing pharma's bad boy reputation. They chat about the current state of pharma's reputation and the influence of the media and pop culture on this, the ways in which pharma can recover and bolster its reputation, and more. And in 'news you might have missed', Hel...

In this week's episode Helena and Isabel were honoured to be joined by Rino Rappuoli, Head of External R&D and Chief Scientist at GSK Vaccines. He discusses his career inspiration and journey; his work on novel scientific concepts such as reverse vaccinology, which modern vaccines are based on; and his interest in meningitis, as well as the lasting impact of COVID-19 on the vaccine landscape, how...

[Yesterday 15:46] Helena Beer Top tips for digital innovation and the future of patient centricity In this week's episode of The GOLD Podcast, Helena is joined by Konrad Dobschuetz, National Director at NHS Innovation Accelerator and Chief Enterprise Officer at UCL Partners, who discusses all things digital innovation. They chat about his transition from the fashion industry to pharma, some digita...

This week's episode features a fascinating conversation with Samin Saeed, UK Chief Scientific Officer and Medical Director at Novartis UK. She discusses a whole host of medical affairs-related issues, including the transition from medicine to pharma, cross-functionality, commercial versus medical affairs, and lots more besides, including a fascinating discussion about leadership, company culture a...

This week, Marc and Helena are joined in the podcast studio by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen, to shed some light on this often-overlooked field of pharma. He discusses his career journey in pharmacovigilance and how, in his experience, the field has changed; the importance of pharmacovigilance as a strategic enabler within businesses; and the outlook for the future...

It's good to be back! To celebrate the launch of Season 3 of The GOLD Podcast, Marc and Helena bring you a special extended version of our conversation with GOLD's latest catalyst interviewee Dr Juby Jacob-Nara, Vice President and Global Medical Head for Respiratory, Allergy and Gastro-Intestinal Diseases, Sanofi. She speaks to Assistant Editor Isabel O'Brien about her move from medicine to medica...

For our fifth and final GOLD Nugget of season 2, Helena looks back to one of our most popular episodes featuring Davidek Herron, Global Head of Digital at Roche. In these snippets, Davidek gives some great insights into what digital transformation means to him, drawing upon his time playing professional basketball in New York to illustrate his move into the pharma industry and some tips on learnin...

In this GOLD nugget, Helena looks back at thoughts shared by Aliya Omer, Vice President and Head of Global Portfolio and Program Strategy at Kite Pharma from our special International Women's Day episode. Aliya reflects on her time playing basketball in her youth and fighting for gender equality both on and off the court, some key role models in her life and the importance of listening to engage r...

This GOLD Nugget episode sees Helena reflect on some of the insights offered by Laurence Woollard, haemophilia patient advocate and Founder and Director of On The Pulse Consultancy. In these clips, Laurence shares his personal experience of living with haemophilia and his journey into patient advocacy, the knowledge gap between the pharmaceutical industry and patients living with rare diseases and...